[1]赵云龙,赵宏达,任凯,等.丙泊酚调节MAPK/ERK信号通路对IL-1β诱导的软骨细胞损伤的改善作用实验研究[J].陕西医学杂志,2025,54(12):1622-1627.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.006]
 ZHAO Yunlong,ZHAO Hongda,REN Kai,et al.Ameliorative effect of propofol on IL-1β-induced chondrocyte injury by regulating MAPK/ERK signaling pathway[J].,2025,54(12):1622-1627.[doi:DOI:10.3969/j.issn.1000-7377.2025.12.006]
点击复制

丙泊酚调节MAPK/ERK信号通路对IL-1β诱导的软骨细胞损伤的改善作用实验研究

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年12期
页码:
1622-1627
栏目:
基础研究
出版日期:
2025-12-05

文章信息/Info

Title:
Ameliorative effect of propofol on IL-1β-induced chondrocyte injury by regulating MAPK/ERK signaling pathway
作者:
赵云龙1赵宏达2任凯3董丽强4
[1.哈尔滨市中医医院手术麻醉科,黑龙江 哈尔滨 150000;2.哈尔滨市第四医院麻醉科,黑龙江 哈尔滨 150026;3.哈尔滨市第一专科医院MECT(麻醉)科,黑龙江 哈尔滨 150000;4.黑龙江中医药大学附属第一医院手术麻醉科,黑龙江 哈尔滨 150040]
Author(s):
ZHAO Yunlong1ZHAO Hongda2REN Kai3DONG Liqiang4
(1.Department of Surgical Anesthesiology,Harbin Hospital of Traditional Chinese Medicine,Harbin 150000,China;2.Department of Anesthesiology,Harbin Fourth Hospital,Harbin 150026,China;3.Department of MECT [Anesthesiology],Harbin First Specialized Hospital,Harbin 150000,China;4.Department of Surgical Anesthesiology,the First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150040,China)
关键词:
软骨细胞损伤丙泊酚丝裂原活化蛋白激酶细胞外信号调节激酶白细胞介素-1β改善作用
Keywords:
Chondrocyte injuryPropofolMitogen-activated protein kinaseExtracellular regulated protein kinaseInterleukin-1βAmeliorative effect
分类号:
R -33
DOI:
DOI:10.3969/j.issn.1000-7377.2025.12.006
文献标志码:
A
摘要:
目的:探讨丙泊酚(PRO)调节丝裂原活化蛋白激酶(MAPK)/细胞外信号调节激酶(ERK)信号通路对白细胞介素-1β(IL-1β)诱导的软骨细胞损伤的改善作用。方法:体外培养人软骨细胞C-28/I2,并随机分为Ctrl组、IL-1β组、PRO低剂量组(12.5 μmol/L PRO)、PRO中剂量组(25 μmol/L PRO)、PRO高剂量组(50 μmol/L PRO)和PRO高剂量+Chicoric acid组(50 μmol/L PRO+10 μmol/L MAPK/ERK信号通路激活剂Chicoric acid),其中对照组常规培养,其余各组均用10 ng/ml IL-1β诱导。CCK-8法检测C-28/I2细胞增殖;流式细胞术检测C-28/I2细胞凋亡;试剂盒检测C-28/I2细胞上清液中氧化应激指标;ELISA法检测C-28/I2细胞上清液中炎症因子水平;Western blot检测C-28/I2细胞中MAPK/ERK信号通路蛋白表达。结果:与IL-1β组比较,Ctrl组C-28/I2细胞存活率、细胞上清液中谷胱甘肽过氧化物酶(GSH-Px)水平降低,凋亡率、丙二醛(MDA)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平及p-p38 MAPK/p38 MAPK、p-ERK1/2/ERK1/2蛋白表达升高(均P<0.05)。与IL-1β组比较,PRO低剂量组、PRO中剂量组和PRO高剂量组C-28/I2细胞存活率、细胞上清液中GSH-Px水平升高,凋亡率、MDA、IL-6、TNF-α水平及p-p38 MAPK/p38 MAPK、p-ERK1/2/ERK1/2蛋白表达降低,且呈剂量依赖性(均P<0.05)。与PRO高剂量组比较,PRO高剂量+Chicoric acid组C-28/I2细胞存活率、细胞上清液中GSH-Px水平降低,凋亡率、MDA、IL-6、TNF-α水平及p-p38 MAPK/p38 MAPK、p-ERK1/2/ERK1/2蛋白表达升高(均P<0.05)。结论:PRO可通过抑制MAPK/ERK信号通路改善IL-1β诱导的软骨细胞损伤。
Abstract:
Objective:To explore the ameliorative effect of propofol (PRO) on IL-1β-induced chondrocyte injury by regulating the MAPK/ERK signaling pathway.Methods:Human chondrocytes C-28/I2 were cultured in vitro and randomly classified into Ctrl group,IL-1β group,low-dose PRO group (12.5 μmol/L PRO),medium-dose PRO group (25 μmol/L PRO),high-dose PRO group (50 μmol/L PRO),and high-dose PRO+Chicolic acid group (50 μmol/L PRO+10 μmol/L MAPK/ERK signaling pathway activator Chicolic acid).The control group was cultured routinely,while the other groups were induced with 10 ng/ml IL-1β.CCK-8 method was used to measure the proliferation of C-28/I2 cells.Flow cytometry was performed to measure apoptosis in C-28/I2 cells.The reagent kit was used to measure oxidative stress indicators in the supernatant.ELISA method was used to detect the inflammatory factors in the supernatant.Western blot was performed to detect the MAPK/ERK signaling pathway proteins in C-28/I2 cells.Results:Compared with the Ctrl group,the IL-1β group showed a decrease in C-28/I2 cell survival rate,GSH-Px in cell supernatant,and an increase in apoptosis rate,MDA,IL-6,TNF-α levels,p-p38 MAPK/p38 MAPK and p-ERK1/2/ERK1/2 proteins (all P<0.05).Compared with the IL-1β group,the low-,medium- and high-dose PRO groups showed an increase in C-28/I2 cell survival rate,GSH-Px in cell supernatant,and a decrease in apoptosis rate,MDA,IL-6,TNF-α levels,p-p38 MAPK/p38 MAPK and p-ERK1/2/ERK1/2 proteins,and the changes were dose-dependent (all P<0.05).The high-dose PRO+Chicolic acid group showed a decrease in C-28/I2 cell survival rate,GSH-Px in cell supernatant,and an increase in apoptosis rate,MDA,IL-6,TNF-α levels,p-p38 MAPK/p38 MAPK and p-ERK1/2/ERK1/2 proteins than the high-dose PRO group (all P<0.05).Conclusion:PRO can ameliorate IL-1β-induced chondrocyte injury by inhibiting MAPK/ERK signaling pathway.

参考文献/References:

[1]JIANG Y.Osteoarthritis year in review 2021:Biology[J].Osteoarthritis Cartilage,2022,30(2):207-215.
[2]ABRAMOFF B,CALDERA F E.Osteoarthritis:Pathology,diagnosis,and treatment options[J].Med Clin North Am,2020,104(2):293-311.
[3]罗江淼,如斯坦木,阿特尔,等.骨关节炎发病机制及治疗研究进展[J].陕西医学杂志,2024,53(7):1006-1009.
[4]ZHANG H J,LIAO H Y,BAI D Y,et al.MAPK/ERK signaling pathway:A potential target for the treatment of intervertebral disc degeneration[J].Biomed Pharmacother,2021,143:112170.
[5]WANG X,ZHANG C,ZOU N,et al.Lipocalin-2 silencing suppresses inflammation and oxidative stress of acute respiratory distress syndrome by ferroptosis via inhibition of MAPK/ERK pathway in neonatal mice[J].Bioengineered,2022,13(1):508-520.
[6]KNIGHTS A J,REDDING S J,MAERZ T.Inflammation in osteoarthritis:The latest progress and ongoing challenges[J].Curr Opin Rheumatol,2023,35(2):128-134.
[7]MOTTA F,BARONE E,SICA A,et al.Inflammaging and osteoarthritis[J].Clin Rev Allergy Immunol,2023,64(2):222-238.
[8]李帆,祖丽娅提·阿热甫江,陈红.丙泊酚通过JAK激酶-信号转导及转录活化因子信号通路抑制类风湿关节炎大鼠炎症反应及滑膜细胞凋亡[J].安徽医药,2022,26(6):1079-1083.
[9]赵欣敏,卢金莹,王高,等.基于AKT/mTOR通路探讨齐墩果酸调控自噬对IL-1β诱导软骨细胞损伤的保护作用[J].中药药理与临床,2024,40(5):57-62.
[10]HAN R H,HUANG H M,HAN H,et al.Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia[J].Mil Med Res,2021,8(1):58.
[11]王双,王正蓉,朱丽英,等.核纤层蛋白A基因通过MAPK通路调控胃癌细胞HGC27的增殖、迁移及凋亡[J].贵州医科大学学报,2024,49(6):781-790,802.
[12]TANG S,ZHANG C,OO W M,et al.Osteoarthritis[J].Nat Rev Dis Primers,2025,11(1):10.
[13]宋阳,徐飞,李丹萍,等.血清miR-155、miR-140、miR-146a对膝关节骨性关节炎的诊断价值及其与病情严重程度的关系[J/OL].空军军医大学学报,1-12[2025-07-23].http://kns.cnki.net/kcms/detail/61.1526.R.20250707.1404.002.html.
[14]胡科迪,刘凯.硫酸氨基葡萄糖联合美洛昔康对膝骨关节炎患者血清FGF-2、TGF-β、IGF-1水平及膝关节运动功能的影响[J].临床误诊误治,2024,37(9):66-70.
[15]張復華,杨观虎,鄭德怡.退化性膝骨关节炎中西医治疗进展[J].陕西中医,2024,45(9):1290-1293,1297.
[16]YUNUS M H M,NORDIN A,KAMAL H.Pathophysiological perspective of osteoarthritis[J].Medicina (Kaunas),2020,56(11):614.
[17]MINNIG M C C,GOLIGHTLY Y M,NELSON A E.Epidemiology of osteoarthritis:Literature update 2022-2023[J].Curr Opin Rheumatol,2024,36(2):108-112.
[18]LIU L,ZHANG W,LIU T,et al.The physiological metabolite α-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress[J].Redox Biol,2023,62:102663.
[19]LEITE C B G,MERKELY G,CHARLES J F,et al.From inflammation to resolution:Specialized pro-resolving mediators in posttraumatic osteoarthritis[J].Curr Osteoporos Rep,2023,21(6):758-770.
[20]WANG C,ZHANG S,HUANG L,et al.Chemerin promotes MAPK/ERK activation to induce inflammatory factor production in rat synoviocytes[J].Exp Ther Med,2022,24(5):684.
[21]LU J,ZHANG H,PAN J,et al.Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways[J].Arthritis Res Ther,2021,23(1):142.
[22]JIANG T,GONG Y,ZHANG W,et al.PD0325901,an ERK inhibitor,attenuates RANKL-induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways[J].Bioorg Chem,2023,132:106321.
[23]KARACAER F,BIRICIK E,ILGINEL M,et al.The anti-inflammatory and antioxidant effects of propofol and sevoflurane in children with cyanotic congenital heart disease[J].J Cardiothorac Vasc Anesth,2023,37(1):65-72.
[24]LI L,LIU X,DU J,et al.Propofol mitigates brain injury and oxidative stress,and enhances GABAA receptor α1 subunit expression in a rat model of lithium chloride-pilocarpine induced status epilepticus[J].Turk J Med Sci,2023,53(5):1058-1066.
[25]叶姣.丙泊酚与七氟醚剂量配伍对合并轻度认知功能障碍的老年股骨颈骨折患者围术期氧化应激反应及术后认知功能的影响[J].陕西医学杂志,2019,48(10):1298-1301.
[26]ZHANG F,WANG Z,SUN B,et al.Propofol Rescued astrocytes from LPS-induced inflammatory response via blocking LncRNA-MEG3/NF-κB axis[J].Curr Neurovasc Res,2022,19(1):5-18.
[27]WANG L,TANG X,LI S.Propofol promotes migration,alleviates inflammation,and apoptosis of lipopolysaccharide-induced human pulmonary microvascular endothelial cells by activating PI3K/AKT signaling pathway via upregulating APOM expression[J].Drug Dev Res,2022,83(2):397-406.

相似文献/References:

[1]霍彦龙,郝璞珩,田 道 △.丙泊酚抑制缺氧/复氧HUVECs细胞中miR15b表达 及细胞凋亡的实验研究*[J].陕西医学杂志,2019,(2):144.
 HUO Yanlong,HAO Puheng,TIAN Dao..Propofol inhibits miR15b expression and apoptosis in hypoxia/reoxygenation HUVECs[J].,2019,(12):144.
[2]杨永斌,杨秀梅.芬太尼复合丙泊酚麻醉在小儿支气管异物取出术中的应用效果[J].陕西医学杂志,2019,(7):882.
 YANG Yongbin,YANG Xiumei..Effect of fentanyl combined with propofol anesthesia on removal of foreign bodies in children[J].,2019,(12):882.
[3]叶 姣.丙泊酚与七氟醚剂量配伍对合并轻度认知功能障碍的老年股骨颈骨折〖JZ〗患者围术期氧化应激反应及术后认知功能的影响*[J].陕西医学杂志,2019,(10):1298.
 YE Jiao..Effects of propofol and sevoflurane on perioperative oxidative stress and postoperative cognitive〖JZ〗 function in elderly patients with femoral neck fracture complicated with mild cognitive impairment[J].,2019,(12):1298.
[4]梁伟华,蒋 淼.丙泊酚减低EZH2对miR-34a抑制效应与肠癌细胞增殖侵袭能力变化的研究[J].陕西医学杂志,2022,51(10):1191.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.004]
 LIANG Weihua,JIANG Miao.Relationship between propofol reducing inhibitory effect of EZH2 on miR-34a and proliferation,invasion of colorectal cancer cells[J].,2022,51(12):1191.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.004]
[5]王岩英,周进国,刘晓宁,等.基于环磷酸腺苷/蛋白激酶A/环磷酸腺苷反应元件结合蛋白通路探究丙泊酚对局灶性脑缺血再灌注大鼠神经功能改善机制[J].陕西医学杂志,2024,(4):455.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.005]
 WANG Yanying,ZHOU Jinguo,LIU Xiaoning,et al.Mechanism of propofol improving neurological function in rats with focal cerebral ischemia-reperfusion based on cAMP/PKA/CREB pathway[J].,2024,(12):455.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.005]
[6]王海龙,夏丰娜,高学锋,等.罗哌卡因调节沉默信息调控基因1/叉头转录因子1信号通路对白细胞介素-1β诱导的软骨细胞损伤的影响实验研究[J].陕西医学杂志,2025,54(3):314.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.005]
 WANG Hailong,XIA Fengna,GAO Xuefeng,et al.Effect of ropivacaine on interleukin-1β-induced chondrocyte injury by regulating the SIRT1/FOXO1 signaling pathway[J].,2025,54(12):314.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.005]

备注/Memo

备注/Memo:
黑龙江省中医药科研项目(ZHY2024-080)
更新日期/Last Update: 2025-12-05